Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2004 1
2006 5
2007 3
2008 5
2009 10
2010 11
2011 13
2012 14
2013 7
2014 4
2015 3
2016 4
2017 13
2018 10
2019 12
2020 12
2021 25
2022 23
2023 14
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Results by year

Citations

29 articles found by citation matching
Show all

Search results

Filters applied: . Clear all
Page 1
The time to include cognition in the multiple sclerosis concept of progression independent from relapse activity is now.
Ziccardi S, Guandalini M, Fuchs TA, Calabrese M, Benedict RH. Ziccardi S, et al. Among authors: calabrese m. Mult Scler. 2024 Aug 28:13524585241264476. doi: 10.1177/13524585241264476. Online ahead of print. Mult Scler. 2024. PMID: 39193704
Progression independent of relapse activity (PIRA) has been recently proposed in multiple sclerosis (MS) as a model identifying a continuous silent progression of disability without the manifestation of new clinical and magnetic resonance imaging (MRI) events that c …
Progression independent of relapse activity (PIRA) has been recently proposed in multiple sclerosis (MS) as a model identifyin …
Classification of upper limb spasticity patterns in patients with multiple sclerosis: a pilot observational study.
Filippetti M, Lugoboni L, Di Censo R, Degli Esposti L, Facciorusso S, Varalta V, Santamato A, Calabrese M, Smania N, Picelli A. Filippetti M, et al. Among authors: calabrese m. J Rehabil Med. 2024 Aug 25;56:jrm40548. doi: 10.2340/jrm.v56.40548. J Rehabil Med. 2024. PMID: 39185546 Free PMC article.
OBJECTIVE: The aim of this study was to provide a classification of the upper limb patterns in patients with upper limb spasticity due to multiple sclerosis. DESIGN: Pilot observational study. PATIENTS: Twenty-five adult patients with multiple sclerosis …
OBJECTIVE: The aim of this study was to provide a classification of the upper limb patterns in patients with upper limb spasticity due to …
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage.
Ziccardi S, Tamanti A, Ruggieri C, Guandalini M, Marastoni D, Camera V, Montibeller L, Mazziotti V, Rossi S, Calderone M, Pizzini FB, Montemezzi S, Magliozzi R, Calabrese M. Ziccardi S, et al. Among authors: calabrese m. Neurol Neuroimmunol Neuroinflamm. 2024 Nov;11(6):e200301. doi: 10.1212/NXI.0000000000200301. Epub 2024 Aug 22. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 39178066 Free PMC article.
BACKGROUND AND OBJECTIVES: Cognitive impairment (CI) in multiple sclerosis (MS) is frequent and determined by a complex interplay between inflammatory and neurodegenerative processes. ...
BACKGROUND AND OBJECTIVES: Cognitive impairment (CI) in multiple sclerosis (MS) is frequent and determined by a complex interp …
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse?
Mazziotti V, Crescenzo F, Turano E, Guandalini M, Bertolazzo M, Ziccardi S, Virla F, Camera V, Marastoni D, Tamanti A, Calabrese M. Mazziotti V, et al. Among authors: calabrese m. J Neuroinflammation. 2024 Aug 21;21(1):209. doi: 10.1186/s12974-024-03193-6. J Neuroinflammation. 2024. PMID: 39169320 Free PMC article. Review.
Specifically, it has been recognized as an essential pro-inflammatory cytokine implicated in multiple sclerosis (MS) pathogenesis and progression. MS is a chronic immune-mediated disease of the central nervous system, characterized by multifocal acute and chronic in …
Specifically, it has been recognized as an essential pro-inflammatory cytokine implicated in multiple sclerosis (MS) pathogene …
Evaluation of cervical spinal cord atrophy using a modified SIENA approach.
Luchetti L, Prados F, Cortese R, Gentile G, Calabrese M, Mortilla M, De Stefano N, Battaglini M; Alzheimer's Disease Neuroimaging Initiative. Luchetti L, et al. Among authors: calabrese m. Neuroimage. 2024 Sep;298:120775. doi: 10.1016/j.neuroimage.2024.120775. Epub 2024 Aug 4. Neuroimage. 2024. PMID: 39106936 Free article.
When comparing a group of 190 Healthy Controls with a group of 65 Multiple Sclerosis patients, SIENA-SC provided significantly higher yearly rates of atrophy in patients than in controls and a lower sample size when measured for treatment effect sizes of 50%, 30% an …
When comparing a group of 190 Healthy Controls with a group of 65 Multiple Sclerosis patients, SIENA-SC provided significantly …
Smouldering-Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions.
Scalfari A, Traboulsee A, Oh J, Airas L, Bittner S, Calabrese M, Garcia Dominguez JM, Granziera C, Greenberg B, Hellwig K, Illes Z, Lycke J, Popescu V, Bagnato F, Giovannoni G. Scalfari A, et al. Among authors: calabrese m. Ann Neurol. 2024 Jul 25. doi: 10.1002/ana.27034. Online ahead of print. Ann Neurol. 2024. PMID: 39051525 Review.
Despite therapeutic suppression of relapses, multiple sclerosis (MS) patients often experience subtle deterioration, which extends beyond the definition of "progression independent of relapsing activity." ...
Despite therapeutic suppression of relapses, multiple sclerosis (MS) patients often experience subtle deterioration, which ext …
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis.
Marastoni D, Turano E, Tamanti A, Colato E, Pisani AI, Scartezzini A, Carotenuto S, Mazziotti V, Camera V, Anni D, Ziccardi S, Guandalini M, Pizzini FB, Virla F, Mariotti R, Magliozzi R, Bonetti B, Steinman L, Calabrese M. Marastoni D, et al. Among authors: calabrese m. Neurol Neuroimmunol Neuroinflamm. 2024 Sep;11(5):e200265. doi: 10.1212/NXI.0000000000200265. Epub 2024 Jun 25. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38917380 Free PMC article.
Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple Sclerosis.
Ciccarelli O, Barkhof F, Calabrese M, De Stefano N, Eshaghi A, Filippi M, Gasperini C, Granziera C, Kappos L, Rocca MA, Rovira À, Sastre-Garriga J, Sormani MP, Tur C, Toosy AT; as the MAGNIMS Study Group. Ciccarelli O, et al. Among authors: calabrese m. Neurology. 2024 Jul 9;103(1):e209444. doi: 10.1212/WNL.0000000000209444. Epub 2024 Jun 18. Neurology. 2024. PMID: 38889384 Free PMC article. Review.
Progression independent of relapse activity (PIRA), a recent concept to formalize disability accrual in multiple sclerosis (MS) independent of relapses, has gained popularity as a potential clinical trial outcome. ...
Progression independent of relapse activity (PIRA), a recent concept to formalize disability accrual in multiple sclerosis (MS …
The neural substrates of social cognition deficits in newly diagnosed multiple sclerosis patients.
Ziccardi S, Genova H, Colato E, Guandalini M, Tamanti A, Calabrese M. Ziccardi S, et al. Among authors: calabrese m. Ann Clin Transl Neurol. 2024 Jul;11(7):1798-1808. doi: 10.1002/acn3.52085. Epub 2024 Jun 13. Ann Clin Transl Neurol. 2024. PMID: 38872257 Free PMC article.
OBJECTIVE: Cognitive and affective symptoms in multiple sclerosis (MS) can be independently impaired and have different pathways of progression. ...
OBJECTIVE: Cognitive and affective symptoms in multiple sclerosis (MS) can be independently impaired and have different pathwa …
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis.
Calabrese M, Preziosa P, Scalfari A, Colato E, Marastoni D, Absinta M, Battaglini M, De Stefano N, Di Filippo M, Hametner S, Howell OW, Inglese M, Lassmann H, Martin R, Nicholas R, Reynolds R, Rocca MA, Tamanti A, Vercellino M, Villar LM, Filippi M, Magliozzi R. Calabrese M, et al. Ann Neurol. 2024 Jul;96(1):1-20. doi: 10.1002/ana.26913. Epub 2024 Apr 3. Ann Neurol. 2024. PMID: 38568026 Review.
Clinical, pathological, and imaging evidence in multiple sclerosis (MS) suggests that a smoldering inflammatory activity is present from the earliest stages of the disease and underlies the progression of disability, which proceeds relentlessly and independently of …
Clinical, pathological, and imaging evidence in multiple sclerosis (MS) suggests that a smoldering inflammatory activity is pr …
178 results